Nina Shah Selected Research

Monoclonal Antibodies

1/2023	Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study.
10/2021	FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.
9/2021	Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.
1/2021	Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.
1/2020	The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nina Shah Research Topics

Disease

85	Multiple Myeloma 05/2024 - 01/2012
25	Neoplasms (Cancer) 04/2024 - 09/2007
15	Hematologic Neoplasms (Hematological Malignancy) 07/2023 - 12/2014
9	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020 - 10/2013
8	Infections 01/2023 - 02/2002
5	Residual Neoplasm 05/2024 - 02/2017
5	Plasma Cell Leukemia 07/2022 - 01/2019
4	Cytokine Release Syndrome 01/2023 - 01/2021
4	Lymphoma (Lymphomas) 01/2017 - 01/2012
3	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2012
3	Pain (Aches) 01/2022 - 02/2005
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 09/2010
3	Fever (Fevers) 01/2021 - 01/2002
3	Disease Progression 11/2019 - 10/2013
3	Mucositis 05/2019 - 01/2016
3	Hodgkin Disease (Hodgkin's Disease) 01/2016 - 11/2012
3	Inflammation (Inflammations) 02/2015 - 02/2005
2	Chromosome Aberrations (Chromosome Abnormalities) 04/2024 - 11/2015
2	cell-associated neurotoxicity 01/2023 - 01/2021
2	Pneumonia (Pneumonitis) 01/2020 - 01/2002
2	Dermatitis 06/2017 - 01/2016
2	Pure Red-Cell Aplasia 05/2016 - 03/2013
2	Amyloidosis 02/2016 - 01/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2014 - 06/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2014 - 06/2014
2	Body Weight (Weight, Body) 04/2014 - 12/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2012 - 01/2012
2	HIV Infections (HIV Infection) 05/2006 - 02/2002
2	Anemia 02/2002 - 01/2002
2	Oral Candidiasis (Thrush) 02/2002 - 01/2002
1	Toxoplasmosis 02/2024
1	Lung Neoplasms (Lung Cancer) 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023
1	Poisoning 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Sudden Infant Death (SID) 01/2023
1	Acidosis 01/2023
1	Cytopenia 01/2023
1	Delirium 01/2023
1	Bone Marrow Diseases (Bone Marrow Disease) 01/2023
1	Hypersensitivity (Allergy) 12/2022
1	Injection Site Reaction 12/2022
1	Neutropenia 12/2022

Drug/Important Bio-Agent (IBA)

21	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2019
15	Lenalidomide (CC 5013)FDA Link 05/2024 - 06/2014
12	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 01/2012
11	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 01/2020
11	B-Cell Maturation AntigenIBA 03/2024 - 01/2020
10	daratumumabIBA 04/2024 - 01/2020
8	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2019
8	Bortezomib (Velcade)FDA Link 04/2024 - 05/2012
8	Busulfan (Busulfex)FDA Link 05/2019 - 11/2012
7	idecabtagene vicleucelIBA 01/2023 - 01/2021
6	trans-crotonin (CTN)IBA 12/2023 - 01/2019
6	Proteasome InhibitorsIBA 01/2023 - 09/2017
5	Monoclonal AntibodiesIBA 01/2023 - 01/2020
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2013
3	VaccinesIBA 12/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2020
3	Rituximab (Mabthera)FDA Link 09/2021 - 11/2015
3	carfilzomibIBA 01/2021 - 01/2020
3	AntigensIBA 01/2020 - 07/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2016
3	fludarabineIBA 01/2019 - 10/2013
3	Gemcitabine FDA Link 06/2017 - 11/2012
2	venetoclaxIBA 07/2022 - 01/2020
2	MethyltransferasesIBA 01/2020 - 01/2016
2	Immunomodulating AgentsIBA 01/2020 - 09/2017
2	FM 100 (FM100)IBA 01/2019 - 10/2013
2	SteroidsIBA 01/2018 - 04/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 11/2016 - 03/2013
2	Amyloid (Amyloid Fibrils)IBA 02/2016 - 01/2012
2	Vorinostat FDA Link 01/2016 - 11/2015
2	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2006 - 02/2005
2	Zidovudine (Retrovir)FDA LinkGeneric 02/2002 - 01/2002
1	Adenosine Monophosphate (AMP)IBA 04/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023
1	pembrolizumabIBA 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	AnionsIBA 01/2023
1	Methanol (Carbinol)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Fomepizole (Antizol)FDA LinkGeneric 01/2023
1	lysine(6)- glutaryl- 2- (hydroxymethyl)anthraquinone LHRH (T 98)IBA 12/2022

Therapy/Procedure

57	Therapeutics 04/2024 - 05/2003
20	Cell Transplantation 05/2024 - 03/2013
20	Hematopoietic Stem Cell Transplantation 02/2024 - 03/2012
20	Transplantation 10/2023 - 11/2012
17	Drug Therapy (Chemotherapy) 03/2022 - 07/2012
15	Stem Cell Transplantation 10/2023 - 09/2010
6	Autologous Transplantation 01/2023 - 01/2018
5	Immunotherapy 01/2021 - 06/2015
2	Salvage Therapy 03/2024 - 01/2022
2	Blood Component Removal (Apheresis) 01/2017 - 07/2011
1	Retreatment 03/2024
1	Palliative Care (Palliative Therapy) 07/2023
1	Renal Dialysis (Hemodialysis) 01/2023
1	Hematopoietic Stem Cell Mobilization 01/2023